This study investigates the combination of chemotherapy and stereotactic body radiotherapy (SBRT) for patients with locally advanced, inoperable pancreatic cancer. The purpose of this study is to explore new treatment strategies for this condition.
The study evaluates the effectiveness and safety of using chemotherapy followed by high-dose SBRT. It focuses on assessing how well this approach works and its safety for patients.
- Who can participate: Adults aged 18 years and older with locally advanced, inoperable pancreatic cancer may participate. Participants must have had no prior systemic therapy and be able to provide written informed consent.
- Study details: Participants will receive chemotherapy followed by ablative SBRT directed at the primary tumor.
How understandable was the trial content above?
Hard to understand
Easy to understand